Skip to content

Pacific Edge Ltd Sustainability Reports

Pacific Edge Limited is a global cancer diagnostics company that specializes in molecular and genomic testing. The company develops and commercializes its Cxbladder suite of urine-based diagnostic tests for the detection and monitoring of bladder cancer.

Sector: Manufacturing

Country: New Zealand

Exchange: New Zealand Exchange (NZX)

LEI: 9845007EDCF068FFEA12

FIGI: BBG001SJN5H0

13 reports from 2011 to 2026